HB Biotech

“HB Biotech is committed to helping patients suffering from mental health issues without the side effects of existing treatements. We have built a novel combination drug (HB-01) that is currently in phase two trials for panic disorder, the first of multiple indications for our therapy. As we build our clinical program, HB Biotech is working closely with the team at Ceretype to provide biological evidence to validate the mechanism of action and treatment effect of HB-01 and help us identify the patients for whom the therapy is most impactful.”